Article Text

Download PDFPDF
Genetic correlation between plasma levels of C4BP isoforms containing β chains and susceptibility to thrombosis
  1. J Esparza-Gordillo1,
  2. J M Soria2,
  3. A Buil2,
  4. J C Souto2,
  5. L Almasy3,
  6. J Blangero3,
  7. S R de Córdoba1,
  8. J Fontcuberta2
  1. 1Departamento de Inmunología, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain
  2. 2Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  3. 3Southwest Foundation for Biomedical Research, San Antonio, TX, USA
  1. Correspondence to:
 Dr J M Soria
 Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, C/Sant Antoni Ma Claret, 167, 08025-Barcelona, Spain; jsoriahsp.santpau.es

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Thrombosis is a complex trait with both genetic and environmental components.1 In general, disease status is a qualitative trait where individuals are diagnosed as affected or unaffected, but it is now accepted that underlying the disease there is a continuum trait termed liability, susceptibility, or risk. Liability cannot be measured directly, but it can be modelled and estimated. Disease results when an individual’s liability is above a critical value or threshold, whereas liability values below the threshold correspond to healthy individuals. These threshold models of an underlying continuous scale of risk allow inferences that are compatible with current models of gene action.2

Quantitative plasma phenotypes, such as those related to haemostasis, are also complex traits, whose regulation depends on multiple genetic and environmental factors.3 Classical statistical methods are unable to quantify or partition the genetic and environmental factors determining the variability in such complex traits. However, variance component methods have been developed which allow the examination of sources of correlation between quantitative physiological measures and disease outcomes.4 These statistical genetic methods also permit the localisation and evaluation of the relative effects of the genes involved.5

We have applied these methods to the Genetic Analysis of Idiopathic Thrombophilia Project (GAIT Project) to characterise the genetic determinants responsible for idiopathic thrombophilia. Using a family based approach, we estimated that idiopathic thrombophilia has a heritability of 0.61, indicating that 61% of variation in liability to thrombosis at the population level can be attributed to genetic factors.6 Phenotypic correlations were also evaluated between 27 plasma phenotypes related to haemostasis and thrombosis liability.6 It was found that genetic factors were mainly responsible for these phenotypic correlations,6 indicating that some of the genes that regulate quantitative variation in these plasma phenotypes also affect the risk of thrombosis. These …

View Full Text

Footnotes

  • This study was supported by grants NIH USA HL70751, FIS 02/0375 from the Fondo Investigación Sanitaria, SAF2002/03449 and SAF2002/01083 from the Spanish Ministry of Science and Technology, 08.6/0028.1/2000 from the Comunidad de Madrid, Fundació “La Caixa”, and Fundació de Investgació Sant Pau. Dr J M Soria is supported by the FIS 99/3048 grant from the Fondo de Investigación Sanitaria. J Esparza-Gordillo is supported by a grant from the Comunidad Autónoma de Madrid. A Buil is supported by the FIS 01/A046 grant from the Fondo Investigación Sanitaria.